Can Dynamic Shared Ownership Revolutionize Pharma Organisational Design And Leadership?
<p>Anderson’s journey towards DSO started during his stint at Roche Pharmaceuticals, where he championed agile practices and embraced the principles of Laloux’s Teal framework, promoting self-management and collaboration. He recognized the limitations of traditional hierarchical structures in stifling innovation and agility, particularly in the face of the pharma industry’s complex challenges. His bold move at Bayer, where he implemented DSO on a company-wide scale, sent shockwaves through the industry. While the results are still unfolding, Anderson’s commitment to empowering employees and fostering collective leadership sets a precedent for a potentially transformative approach to pharma leadership.</p>
<p><a href="https://medium.com/@gianlucaradesich/can-dynamic-shared-ownership-revolutionize-pharma-organisational-design-and-leadership-715c3a7fbc8d"><strong>Read More</strong></a></p>